Applications

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application

Abreviews

Notes

IHC-Fr

1/2000.

Target

Involvement in diseaseDefects in ATP13A2 are the cause of Kufor-Rakeb syndrome (KRS) [MIM:606693]; also known as Parkinson disease type 9 (PARK9). KRS is a rare hereditary disease with juvenile onset. In addition to typical signs of Parkinson disease, affected individuals show symptoms of more widespread neurodegeneration, including dementia.

Anti-ATP13A2 antibody images

Immunohistochemistry (Frozen sections) - ATP13A2 antibody (ab43074)

Ab43074 staining ATP13A2 by immunohistochemistry using frozen tissue.

The cryostat section of the rat spinal cord was incubated in ab43074 to the mouse ATPase protein at the dilution of 1:1000 overnight followed with a biotinylated secondary antibody and ABC kit. The section was developed in diaminobenzidine solution and enhanced in the presence of nickel sulphate. Cell bodies and nerve fibers in the trigeminal nerve are stained.

References for Anti-ATP13A2 antibody (ab43074)

ab43074
has not yet been referenced specifically in any publications.

Publishing research using ab43074? Please let us know so that we can cite the reference in this datasheet.